OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves adjusting various variables, including cell line development, media formulation, and bioreactor conditions. A key goal is to increase antibody titer while lowering production costs and